Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 3,062.65
-12.30 (-0.40%)
At close: Jun 19, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 398.35 billion as of June 22, 2026. Its market cap has increased by 27.04% in one year.
Market Cap
398.35B
Enterprise Value
394.31B
Revenue
54.53B
Ranking
n/a
PE Ratio
37.72
Stock Price
3,062.65
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 398.35B, an increase of 70,306.08%. That is a compound annual growth rate of 31.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 382.81B | 10.70% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |
| Granules India | 194.73B |